The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Supplemental Guidance on Identifying Pickup Copy
-
Hello @Manufacturer and @Agency
Please see additional guidance on submission requirements documents created in collaboration with bMod Communications. This document provides supplemental guidance on how to properly identify pickup copy to get the most out of ARO timelines and reduced fees for pieces with large percentages of pickup.
Alternative ways to meet the requirements are showcased in the examples to help you integrate these new practices into your workflows.
